Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations

References

• Abbasi, M., Sadeghi-Aliabadi, H., & Amanlou, M. (2018). 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold. Journal of Biomolecular Structure and Dynamics, 36(6), 1463–1478. doi:10.1080/07391102.2017.1326319.
   PubMed Web of Science ®Google Scholar
• Chai, T., & Draxler, R. R. (2014). Root mean square error (RMSE) or mean absolute error (MAE)? Geoscientific Model Development, 7(3), 1247–1250. doi:10.5194/gmd-7-1247-2014.
   Web of Science ®Google Scholar
• Cheng, P., Li, J., Wang, J., Zhang, X., & Zhai, H. (2018). Investigations of FAK inhibitors: A combination of 3D-QSAR, docking, and molecular dynamics simulations studies. Journal of Biomolecular Structure and Dynamics, 36(6), 1529–1549. doi:10.1080/07391102.2017.1329095.
   PubMed Web of Science ®Google Scholar
• Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of the American Chemical Society, 110(18), 5959–5967. doi:10.1021/ja00226a005.
   PubMed Web of Science ®Google Scholar
• De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016). Role of molecular dynamics and related methods in drug discovery. Journal of Medicinal Chemistry, 59(9), 4035–4061. doi:10.1021/acs.jmedchem.5b01684.
   PubMed Web of Science ®Google Scholar
• Ferreira, G. L., dos Santos, N. R., Oliva, G., & Andricopulo, D. A. (2015). Molecular docking and structure-based drug design strategies. Molecules, 20(7), 13384–13421. doi:10.3390/molecules2007, 13384.
   PubMed Web of Science ®Google Scholar
• Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity—A rapid access to atomic charges. Tetrahedron, 36(22), 3219–3228. doi:10.1016/0040-4020(80)80168-2.
   Web of Science ®Google Scholar
• Han, H., Yang, X., Pandiyan, K., & Liang, G. (2013). Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells. PLoS One, 8(9), e75136. doi:10.1371/journal.pone.0075136.
   PubMed Web of Science ®Google Scholar
• Harris, W. J., Huang, X., Lynch, J. T., Spencer, G. J., Hitchin, J. R., Li, Y., …, Somervaille, T. C. P. (2012). The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell, 21(4), 473–487. doi:10.1016/j.ccr.2012.03.014.
   PubMed Web of Science ®Google Scholar
• Hassanzadeh, Z., Kompany-Zareh, M., Ghavami, R., Gholami, S., & Malek-Khatabi, A. (2015). Combining radial basis function neural network with genetic algorithm to QSPR modeling of adsorption on multi-walled carbon nanotubes surface. Journal of Molecular Structure, 1098, 191–198. doi:10.1016/j.molstruc.2015.05.039.
   Web of Science ®Google Scholar
• Huang, J., Sengupta, R., Espejo, A. B., Lee, M. G., Dorsey, J. A., Richter, M., …, Berger, S. L. (2007). p53 is regulated by the lysine demethylase LSD1. Nature, 449(7158), 105. doi:10.1038/nature06092.
   PubMed Web of Science ®Google Scholar
• Karasulu, B., Patil, M., & Thiel, W. (2013). Amine oxidation mediated by lysine-specific demethylase 1: Quantum mechanics/molecular mechanics insights into mechanism and role of lysine 661. Journal of the American Chemical Society, 135(36), 13400–13413. doi:10.1021/ja403582u.
   PubMed Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37(24), 4130–4146. doi:10.1021/jm00050a010.
   PubMed Web of Science ®Google Scholar
• Kontaki, H., & Talianidis, I. (2010). Lysine methylation regulates E2F1-induced cell death. Molecular Cell, 39(1), 152–160. doi:10.1016/j.molcel.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa–A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. doi:10.1021/ci500020m.
   PubMed Web of Science ®Google Scholar
• Laurent, B., Ruitu, L., Murn, J., Hempel, K., Ferrao, R., Xiang, Y., …, Shi, Y. (2015). A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation. Molecular Cell, 57(6), 957–970. doi:10.1016/j.molcel.2015.01.010.
   PubMed Web of Science ®Google Scholar
• Li, Z.-H., Liu, X.-Q., Geng, P.-F., Suo, F.-Z., Ma, J.-L., Yu, B., …, Liu, H.-M. (2017). Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine derivatives as novel LSD1 inhibitors. ACS Medicinal Chemistry Letters, 8(4), 384–389. doi:10.1021/acsmedchemlett.6b00423.
   PubMed Web of Science ®Google Scholar
• Lim, S., Janzer, A., Becker, A., Zimmer, A., Schüle, R., Buettner, R., & Kirfel, J. (2010). Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis, 31(3), 512–520. doi:10.1093/carcin/bgp324.
   PubMed Web of Science ®Google Scholar
• Lynch, J. T., Harris, W. J., & Somervaille, T. C. P. (2012). LSD1 inhibition: A therapeutic strategy in cancer? Expert Opinion on Therapeutic Targets, 16(12), 1239–1249. doi:10.1517/14728222.2012.722206.
   PubMed Web of Science ®Google Scholar
• Ma, L.-Y., Zheng, Y.-C., Wang, S.-Q., Wang, B., Wang, Z.-R., Pang, L.-P., …, Liu, H.-M. (2015). Design, synthesis, and structure–activity relationship of novel LSD1 inhibitors based on pyrimidine–thiourea hybrids as potent, orally active antitumor agents. Journal of Medicinal Chemistry, 58(4), 1705–1716. doi:10.1021/acs.jmedchem.5b00037.
   PubMed Web of Science ®Google Scholar
• Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015). Role of computer-aided drug design in modern drug discovery. Archives of Pharmacal Research, 38(9), 1686–1701. doi:10.1007/s12272-015-0640-5.
   PubMed Web of Science ®Google Scholar
• Maes, T., Mascaró, C., Tirapu, I., Estiarte, A., Ciceri, F., Lunardi, S., …, Buesa, C. (2018). ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia. Cancer Cell, 33(3), 495–511.e4. doi:10.1016/j.ccell.2018.02.002.
   PubMed Web of Science ®Google Scholar
• McAllister, T. E., England, K. S., Hopkinson, R. J., Brennan, P. E., Kawamura, A., & Schofield, C. J. (2016). Recent progress in histone demethylase Inhibitors. Journal of Medicinal Chemistry, 59(4), 1308–1329. doi:10.1021/acs.jmedchem.5b01758.
   PubMed Web of Science ®Google Scholar
• McGrath, J., & Trojer, P. (2015). Targeting histone lysine methylation in cancer. Pharmacology & Therapeutics, 150, 1–22. doi:10.1016/j.pharmthera.2015.01.002.
   PubMed Web of Science ®Google Scholar
• Mei, D., Yin, Y., Wu, F., Cui, J., Zhou, H., Sun, G., …, Feng, Y. (2015). Discovery of potent and selective urea-based ROCK inhibitors: Exploring the inhibitor’s potency and ROCK2/PKA selectivity by 3D-QSAR, molecular docking and molecular dynamics simulations. Bioorganic & Medicinal Chemistry, 23(10), 2505–2517. doi:10.1016/j.bmc.2015.03.047.
   PubMed Web of Science ®Google Scholar
• Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H. F. M., …, Schüle, R. (2005). LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature, 437(7057), 436. doi:10.1038/nature04020.
   PubMed Web of Science ®Google Scholar
• Mohammad, H. P., Smitheman, K. N., Kamat, C. D., Soong, D., Federowicz, K. E., Van Aller, G. S., …, Kruger, R. G. (2015). A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC. Cancer Cell, 28(1), 57–69. doi:10.1016/j.ccell.2015.06.002.
   PubMed Web of Science ®Google Scholar
• Mohammad, H., Smitheman, K., van Aller, G., Cusan, M., Kamat, S., Liu, Y., …, Kruger, R. (2014). 212 Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552. European Journal of Cancer, 50, 72. doi:10.1016/S0959-8049(14)70338-7.
   Web of Science ®Google Scholar
• Mould Daniel, P., McGonagle Alison, E., Wiseman Daniel, H., Williams Emma, L., & Jordan Allan, M. (2014). Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: Clinical significance and progress to date. Medicinal Research Reviews, 35(3), 586–618. doi:10.1002/med.21334.
   PubMed Web of Science ®Google Scholar
• Niebel, D., Kirfel, J., Janzen, V., Höller, T., Majores, M., & Gütgemann, I. (2014). Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms. Blood, 124(1), 151. doi:10.1182/blood-2014-04-569525.
   PubMed Web of Science ®Google Scholar
• Ojha, P. K., Mitra, I., Das, R. N., & Roy, K. (2011). Further exploring rm2 metrics for validation of QSPR models. Chemometrics and Intelligent Laboratory Systems, 107(1), 194–205. doi:10.1016/j.chemolab.2011.03.011.
   Web of Science ®Google Scholar
• Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011). PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. Journal of Chemical Theory and Computation, 7(2), 525–537. doi:10.1021/ct100578z.
   PubMed Web of Science ®Google Scholar
• Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., …, Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics, 29(7), 845–854. doi:10.1093/bioinformatics/btt055.
   PubMed Web of Science ®Google Scholar
• Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., …, Kirfel, J. (2009). Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy. Cancer Research, 69(5), 2065. doi:10.1158/0008-5472.CAN-08-1735.
   PubMed Web of Science ®Google Scholar
• Sepehri, B., & Ghavami, R. (2017). Molecular docking and CoMFA studies of thiazoloquin(az)olin(on)es as CD38 inhibitors: Determination of inhibitory mechanism, pharmacophore interactions, and design of new inhibitors. Journal of Biomolecular Structure and Dynamics, 35(9), 1890–1898. doi:10.1080/07391102.2016.1197152.
   PubMed Web of Science ®Google Scholar
• Sepehri, B., Hassanzadeh, Z., & Ghavami, R. (2016). Pharmacophore interactions analysis and prediction of inhibitory activity of 1,7-diazacarbazoles as checkpoint kinase 1 inhibitors: Application of molecular docking, 3D-QSAR and RBF neural network. Journal of the Iranian Chemical Society, 13(8), 1525–1537. doi:10.1007/s13738-016-0869-z.
   Web of Science ®Google Scholar
• Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., …, Shi, Y. (2004). Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119(7), 941–953. doi:10.1016/j.cell.2004.12.012.
   PubMed Web of Science ®Google Scholar
• Sorna, V., Theisen, E. R., Stephens, B., Warner, S. L., Bearss, D. J., Vankayalapati, H., & Sharma, S. (2013). High-throughput virtual screening identifies novel N′-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors. Journal of Medicinal Chemistry, 56(23), 9496–9508. doi:10.1021/jm400870h.
   PubMed Web of Science ®Google Scholar
• Tropsha, A. (2010). Best practices for QSAR model development, validation, and exploitation. Molecular Informatics, 29(6–7), 476–488. doi:10.1002/minf.201000061.
   PubMed Web of Science ®Google Scholar
• Verma, J., Khedkar, V. M., & Coutinho, E. C. (2010). 3D-QSAR in drug design – A review. Current Topics in Medicinal Chemistry, 10(1), 95–115. doi:10.2174/156802610790232260.
   PubMed Web of Science ®Google Scholar
• Wu, F., Zhou, C., Yao, Y., Wei, L., Feng, Z., Deng, L., & Song, Y. (2016). 3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1. Journal of Medicinal Chemistry, 59(1), 253–263. doi:10.1021/acs.jmedchem.5b01361.
   PubMed Web of Science ®Google Scholar
• Zheng, Y.-C., Ma, J., Wang, Z., Li, J., Jiang, B., Zhou, W., …, Liu, H.-M. (2015). A systematic review of histone lysine-specific demethylase 1 and its inhibitors. Medicinal Research Reviews, 35(5), 1032–1071. doi:10.1002/med.21350.
   PubMed Web of Science ®Google Scholar
• Zhou, S., Fang, D., Tan, S., Lin, W., Wu, W., & Zheng, K. (2017). Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y12 by 3D-QSAR, docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 35(13), 2938–2965. doi:10.1080/07391102.2016.1237381.
   PubMed Web of Science ®Google Scholar